Could IQIYI Stock Double by 2027? The AI Turnaround Tale
iQIYI is betting on AI to revive growth as its core subscription business falters. With Nadou Pro signing thousands o...
Why Zero Based Budgeting Works
Explore the proven benefits of zero based budgeting and how it creates accountability and tangible financial outcomes.
22,633 articles
SpaceX’s Record Wall Street IPO Sparks Debate Across Markets
SpaceX is preparing the largest IPO in history, valued near $1.77 trillion, as Wall Street debates whether AI-driven ...
China Follows Musk Very Closely as SpaceX IPO Sparks
SpaceX’s highly anticipated IPO faces a major twist as it bars Chinese investors, while Chinese space startups pivot ...
Bitcoin Recovery Begins as SpaceX IPO Shatters Records
Bitcoin stabilizes after a volatile week, signaling a potential turn for BTC as investors eye SpaceX's blockbuster IP...
A $750,000 Portfolio That Quietly Pays More
A disciplined income plan built around a $750,000 portfolio can generate reliable cash flow, potentially exceeding to...
Today’s Market Hits Warning Signals as AI Rally Cools
AI-led gains cool as a quintet of warning signs reappear, drawing parallels to the late-2000s Nasdaq run. Investors b...
Stock Market Today, June: SpaceX IPO Sparks Midday Rally
A blockbuster SpaceX IPO sparks a midday rally as AI optimism and falling oil prices lift major indices. This guide b...
Important Ripple (XRP) Update: Ripple Expands Africa
Ripple announces a strategic investment in Flutterwave to accelerate RLUSD and XRPL-enabled payments across Africa, p...
Lamacchia Realty Gains Vermont License, Expands NE Footprint
Lamacchia Realty gains Vermont license, completing its New England footprint after a strategic acquisition. Six Vermo...
Live Nasdaq Composite: Tech Strength Lifts Markets
Tech-led gains paced a Nasdaq climb as investors reassessed hawkish Fed signals. The index rose, while traders weighe...
XRP’s 2-Month Hits Make-Or-Break: What Comes Next Ahead
A leading crypto analyst says XRP has hit a critical RSI threshold, with the two-month reading near 50 as price sits ...
AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status